StoryCompare
HEALTH08/29/26

FDA Approves Pancreatic Cancer Pill

The FDA approved Rasonque, a new once-daily pill targeting the most common form of pancreatic cancer.

FDA Approves Pancreatic Cancer Pill
Photo: Fox News Health

FRAMING NPR Health emphasized Scientific Breakthrough; Fox News Health emphasized FDA Speed & Industry Detail.

WHAT BOTH SIDES REPORT

  • ▸The approval covers the most common type of pancreatic cancer, a historically hard-to-treat disease. — NPR Health, Fox News Health

LEFT / CENTER-LEFT

  • ▸The drug offers a new approach by blocking a protein that fuels tumor growth in the vast majority of cases. — NPR Health
  • ▸Coverage framed the approval as a landmark scientific breakthrough for a deadly cancer. — NPR Health

RIGHT / CENTER-RIGHT

  • ▸Rasonque is manufactured by Revolution Medicines in California and taken as a once-daily tablet. — Fox News Health
  • ▸The FDA approved it more than six months ahead of its review deadline. — Fox News Health